SCA
MDT icon

Strategic Capital Alternatives’s Medtronic MDT Stock Holding History

Strategic Capital Alternatives’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,381
Closed -$253K – 402
2015
Q2 		$253K Hold
3,381
– – 0.06% 178
2015
Q1 		$264K Buy
+3,381
New +$256K 0.07% 153
2014
Q4 		– Sell
-2,570
Closed -$159K – 239
2014
Q3 		$159K Buy
+2,570
New +$163K 0.06% 142

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Strategic Capital Alternatives's MDT Position: Q3 2015 in Review

Strategic Capital Alternatives sold out of Medtronic (MDT) in Q3 2015, closing a stake of 3,381 shares — an estimated $253K sold.

Strategic Capital Alternatives first reported a position in MDT in Q3 2014 and held it in 3 quarters. The position peaked at $264K in Q1 2015. 1,210 funds tracked by Wall St. Rank hold MDT as of Q3 2015.

  • Strategic Capital Alternatives reported no remaining Medtronic position as of Q3 2015 after selling out during the quarter.
  • Strategic Capital Alternatives sold 3,381 Medtronic shares in Q3 2015, an estimated $253K.
  • Strategic Capital Alternatives first reported a position in Medtronic in Q3 2014 and held it in 3 quarters.
  • Strategic Capital Alternatives's Medtronic position peaked at $264K in Q1 2015.
  • 1,210 funds tracked by Wall St. Rank held Medtronic as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.